Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie L Adams

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
NPJ Parkinson'S Disease|April 17, 2023
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD studyJamie L Adams, Tairmae Kangarloo, Brian Tracey, et al.
Neurology|January 13, 2026
CSF α-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge GapsDavid G Coughlin, Charles H Adler, William Barbosa, et al.
Annals of Clinical and Translational Neurology|December 22, 2020
Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD)Ruth B Schneider, Larsson Omberg, Eric A Macklin, et al.
Journal of Parkinson'S Disease|May 24, 2020
Deep Phenotyping of Parkinson's DiseaseE Ray Dorsey, Larsson Omberg, Emma Waddell, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
NPJ Parkinson'S Disease|April 17, 2023
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD studyJamie L Adams, Tairmae Kangarloo, Brian Tracey, et al.
Neurology|January 13, 2026
CSF α-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge GapsDavid G Coughlin, Charles H Adler, William Barbosa, et al.
Annals of Clinical and Translational Neurology|December 22, 2020
Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD)Ruth B Schneider, Larsson Omberg, Eric A Macklin, et al.
Journal of Parkinson'S Disease|May 24, 2020
Deep Phenotyping of Parkinson's DiseaseE Ray Dorsey, Larsson Omberg, Emma Waddell, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Pageof 5